NIH-funded research R01 grant

Exosomes and skin healing in diabetes

Official title: Exosomes in wound healing

Funded at University of Pittsburgh at Pittsburgh · NIH-11360166 · Data updated 2026-11-12

A study exploring how tiny vesicles from skin cells communicate with immune cells to improve healing of diabetic wounds.

More Wound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startAugust 22, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$692,804
NIH project number4R01DK129592-04
Project IDNIH-11360166 on NIH RePORTER

Who could benefit from this research

Could help

Adults with diabetes who have chronic, non-healing wounds may be eligible for related studies or future trials.

Less likely to help

People without diabetes or with acute wounds may not directly benefit from this research.

What this research studies

If you have diabetes and struggle with slow-healing wounds, this project looks at how skin cells release small packages that talk to immune cells at the wound site. The researchers will study how these exosomes deliver genetic messages and how a specific molecule, miR-21, might help turn off prolonged inflammation. They will also examine how diabetes changes the surface of these exosomes and whether that affects delivery to macrophages that are critical for healing. The goal is to uncover new ways to promote timely, healthy wound repair by fixing the cell-to-cell communication at the wound edge.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that hasten healing for diabetic wounds by improving the body’s own cell communication.

How similar studies have gone: Previous related work has shown that exosomes can influence wound inflammation, with potential but still evolving translational benefits.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Ghatak, Subhadip — University of Pittsburgh at Pittsburgh
  • Study coordinator: Ghatak, Subhadip

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.